[mailpoet_page]

Tirzepatide SUMMIT Trial Results in HFpEF and Obesity
The SUMMIT trial studied tirzepatide in people with heart failure with preserved ejection fraction (HFpEF) and obesity. Learn about the study design, results, safety findings, and what the trial reported.


